Document is current
Any future updates will be listed below
-
Authors
Malard, Florent
Neri, Paola
Bahlis, Nizar J. http://orcid.org/0000-0001-7353-7034
Terpos, Evangelos
Moukalled, Nour
Hungria, Vania T. M. http://orcid.org/0000-0002-4327-1957
Manier, Salomon
Mohty, Mohamad http://orcid.org/0000-0002-7264-808X
- License Information
-
More Information
Article History
Accepted: 16 May 2024
First Online: 27 June 2024
Competing interests
: F.M. reports honoraria from BMS, Therakos/Mallinckrodt, Sanofi, JAZZ Pharmaceuticals, Gilead, Novartis, AstraZeneca and MSD, all outside the scope of this work. P.N. reports honoraria from Pfizer, BMS, Janssen and Sanofi, and is a consultant/advisory board member for BMS and Janssen. N.J.B. reports honoraria from Amgen, BMS, Sanofi, Pfizer and Janssen, and is a consultant/advisory board member for BMS, Janssen and Pfizer. V.T.M.H. reports honoraria from AbbVie, Amgen, BMS, GSK, Janssen, Sanofi and Takeda. S.M. reports consulting activity and research fundings from Abbvie, Adaptive Biotechnology, Amgen, Bristol Myers Squibb, GlaxoSmithKline, Janssen, Novartis, Pfizer, Regeneron, Roche, Sanofi and Takeda. M.M. reports grants, lecture honoraria and research support from Adaptive Biotechnologies, Amgen, Astellas, BMS-Celgene, GlaxoSmithKline, Janssen, JAZZ Pharmaceuticals, Novartis, Pfizer, Takeda and Sanofi, all outside the scope of this work. The other authors declare no competing interests.
